When breaking silos becomes the CEO’s business strategy to an $80 Billion Market Capitalisation
latestageinsider.substack.com
Hey, I'm Zina Sarif, the founder and CEO of Yendou. A ClinOps Platform designed to accelerate clinical trials delivery to sites. Each week, I chat with executives from the Life Sciences Industry, to discuss the game of clinical trials, the rising costs, the urge to innovate, the pressure for speed, and how to navigate operational inefficiencies on the road to commercialization. Here, I share with you some nuggets from the room. Make sure you subscribe!
When breaking silos becomes the CEO’s business strategy to an $80 Billion Market Capitalisation
When breaking silos becomes the CEO’s…
When breaking silos becomes the CEO’s business strategy to an $80 Billion Market Capitalisation
Hey, I'm Zina Sarif, the founder and CEO of Yendou. A ClinOps Platform designed to accelerate clinical trials delivery to sites. Each week, I chat with executives from the Life Sciences Industry, to discuss the game of clinical trials, the rising costs, the urge to innovate, the pressure for speed, and how to navigate operational inefficiencies on the road to commercialization. Here, I share with you some nuggets from the room. Make sure you subscribe!